Johny Marpaung
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Perbandingan berat badan pada akseptor kontrasepsi hormonal oral kombinasi sebelum, sesudah 6 bulan dan 12 bulan penggunaan Dewi Andriyati; Rusli P. Barus; Khairani Sukatendel; Muldjadi Affendy; Henry Salim Siregar; Johny Marpaung
Majalah Kedokteran Nusantara The Journal Of Medical School Vol 47, No 3 (2014): The Journal of Medical School
Publisher : Fakultas Kedokteran USU

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background : Hormonal contraceptive is the most effective and reversible contraceptive method to prevent a pregnancy. Combined hormonal oral contraceptive primarily work by preventing ovulation. Ovulation was blocked by an action in hypothalamushypophyse-ovarium axys to reduce luteinizing hormone (LH) dan folicle-stimulating hormone (FSH). One of side effect of combined hormonal oral contraceptive pill use is increase the body weight, especially in the first year of use. Because of this side effect can lead to noncompliance or discontinuation of COCs, it takes knowledge of the patients about the side effects that can occur and how to prevent it.Methods : This study is observational analytic, which uses secondary data from medical records of family planning acceptors who use combined hormonal oral contraceptive pill for at least 12 months which is carried out in December 2014 - January 2015 in Public Health Center Helvetia Medan.Results : Mean value of maternal body weight before use of combined hormonal oral contraceptive pill is 57.35 kg, after 6 months of use is 58 kg, and after 12 months of use is 58.28 kg. Based on these results, with the paired t-test between maternal body weight before and after 6 months of use, it gets p value <0.05, which means there is a significant difference between body weight before and after 6 months use of combined hormonal oral contraceptive pill. In the paired t-test comparing the maternal body weight before and after 12 months of use, it gets p value <0.05, which showed a significant difference between body weight before and after 12 months use of combined hormonal oral contraceptive pill. And paired t-test comparing body weight after 6 months and 12 months of use, it gets p value <0.05, which means there is a significant difference between body weight after 6 months and after 12 months use of combined hormonal oral contraceptive pill.Conclusion : There is a significant maternal weight gain before, after 6 months and after 12 months use of combined hormonal oral contraceptive pill.Keywords : body weight, oral contraceptive, family planning
Analisa kasus kista ovarium di Rumah Sakit Umum Pusat (RSUP) Haji Adam Malik Medan periode I Januari 2010 - 31 Desember 2012 Dona Wirniaty; M. Fidel G Siregar; Rushakim Lubis; Henry Salim Siregar; Iman Helmi Effendi; Johny Marpaung
Majalah Kedokteran Nusantara The Journal Of Medical School Vol 48, No 1 (2015): The Journal of Medical School
Publisher : Fakultas Kedokteran USU

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Introduction : Ovarían cysts are cystic neoplasms derived from ovarian tissue, can be benign or malignant. Characteristics ofovarian cysts is importantto be known, such as body mass index and risk ofmaligriancy index. Not only to be able to assess risk factors but also early detection prompt treatment to prevent progression to ovarian cancer.Methods : This is a descriptive study, conducted in Department of Obstetrics and Gynecology Hospital, Adam Malik Medan Medical records from all patients who will undergo elective surgery for ovarian cysts from January Pt 2010 to December 31th 2012 was collected. Data was analyzed descriptively and analytically with chi square by level of significance in this study was p<O.05.Results : There were 327 patients with ovarian cyst undergoing elective surgery in H. Adam Malik Hospital from January 2010  to December 201 2 but only I 99 were included in the study. Majority of patients with malignant ovarian cysts aged 51 years old (38.9%), number of pañty 2-5 (41 .7%), menarche at 1 3-16 years old (72.2%), BMI normoweight (44, 4%), levels of CA 125> 35 U/ml (95.8%), and the RMI > 250 (88.9%). Majority of patients with benign ovarian cysts aged 31-40 year olds (28.3%), parity 2-5 (46.5%), menarche at 13-16 years old (85.4%), BMI obese (44.9%), CA 125 levels similar, and RML 250 (63.8%).  The most common ovarian cyst is malignant adenocarcinoma (72 patients, 36.2%). This study showed that BMI (p=O.OO8) and RMI (jsO.OO1 ) are associated with ovarian cyst. Conclusion: This study showed that there is association of body mass index and risk of malignancy index with ovarian cysts.  Need further research with larger population samples. Keywords : Ovarían cysts; Body Mass Index; Risk of Malignancy index